egfr inhibitors as adjuvant therapy in nsclc
Published 6 years ago • 103 plays • Length 3:41Download video MP4
Download video MP3
Similar videos
-
8:44
adjuvant egfr inhibition in patients with nsclc
-
4:38
egfr tkis as adjuvant therapy in nsclc
-
2:41
egfr tkis in the adjuvant setting in nsclc
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
1:02:05
adjuvant egfr-targeted therapy as a game changer in multimodal nsclc management
-
4:25
adaura: osimertinib as adjuvant therapy in stage iii egfr nsclc
-
10:45
debate: adjuvant egfr-directed therapy for patients with early stage nsclc? - no
-
3:52
is adjuvant chemotherapy in egfr mutated nsclc still required?
-
14:30
adjuvant therapy for egfr mutant nsclc
-
6:14
third-generation egfr inhibitors in nsclc
-
4:48
third-generation egfr inhibitors in nsclc
-
6:46
selecting a first-line egfr inhibitor in nsclc
-
3:35
novel egfr inhibitor combinations for nsclc
-
7:31
newer egfr inhibitors in nsclc
-
7:51
nsclc: egfr inhibition and resistance mechanisms
-
1:00:53
drs. sepesi & cascone discuss egfr-targeted therapy in early-stage nsclc: https://bit.ly/3ozllfo
-
4:59
egfr therapy in nsclc
-
8:30
third-generation egfr inhibitors in nsclc
-
4:28
overcoming resistance to egfr inhibitors in nsclc